scholarly journals Operationalizing Cooperative Research for Infectious Disease Surveillance: Lessons Learned and Ways Forward

2021 ◽  
Vol 9 ◽  
Author(s):  
Kenneth B. Yeh ◽  
Falgunee K. Parekh ◽  
Kairat Tabynov ◽  
Kaissar Tabynov ◽  
Roger Hewson ◽  
...  

The current COVID-19 pandemic demonstrates the need for urgent and on-demand solutions to provide diagnostics, treatment and preventative measures for infectious disease outbreaks. Once solutions are developed, meeting capacities depends on the ability to mitigate technical, logistical and production issues. While it is difficult to predict the next outbreak, augmenting investments in preparedness, such as infectious disease surveillance, is far more effective than mustering last-minute response funds. Bringing research outputs into practice sooner rather than later is part of an agile approach to pivot and deliver solutions. Cooperative multi- country research programs, especially those funded by global biosecurity programs, develop capacity that can be applied to infectious disease surveillance and research that enhances detection, identification, and response to emerging and re-emerging pathogens with epidemic or pandemic potential. Moreover, these programs enhance trust building among partners, which is essential because setting expectation and commitment are required for successful research and training. Measuring research outputs, evaluating outcomes and justifying continual investments are essential but not straightforward. Lessons learned include those related to reducing biological threats and maturing capabilities for national laboratory diagnostics strategy and related health systems. Challenges, such as growing networks, promoting scientific transparency, data and material sharing, sustaining funds and developing research strategies remain to be fully resolved. Here, experiences from several programs highlight successful partnerships that provide ways forward to address the next outbreak.

2021 ◽  
Vol 8 ◽  
Author(s):  
Ju Jiang ◽  
Christina M. Farris ◽  
Kenneth B. Yeh ◽  
Allen L. Richards

Cooperative research that addresses infectious disease surveillance and outbreak investigations relies heavily on availability and effective use of appropriate diagnostic tools, including serological and molecular assays, as exemplified by the current COVID-19 pandemic. In this paper, we stress the importance of using these assays to support collaborative epidemiological studies to assess risk of rickettsial disease outbreaks among international partner countries. Workforce development, mentorship, and training are important components in building laboratory capability and capacity to assess risk of and mitigate emerging disease outbreaks. International partnerships that fund cooperative research through mentoring and on-the-job training are successful examples for enhancing infectious disease surveillance. Cooperative research studies between the Naval Medical Research Center's Rickettsial Diseases Research Program (RDRP) and 17 institutes from nine countries among five continents were conducted to address the presence of and the risk for endemic rickettsial diseases. To establish serological and molecular assays in the collaborative institutes, initial training and continued material, and technical support were provided by RDRP. The laboratory methods used in the research studies to detect and identify the rickettsial infections included (1) group-specific IgM and IgG serological assays and (2) molecular assays. Twenty-six cooperative research projects performed between 2008 and 2020 enhanced the capability and capacity of 17 research institutes to estimate risk of rickettsial diseases. These international collaborative studies have led to the recognition and/or confirmation of rickettsial diseases within each of the partner countries. In addition, with the identification of specific pathogen and non-pathogen Rickettsia species, a more accurate risk assessment could be made in surveillance studies using environmental samples. The discoveries from these projects reinforced international cooperation benefiting not only the partner countries but also the scientific community at large through presentations (n = 40) at international scientific meetings and peer-reviewed publications (n = 18). The cooperative research studies conducted in multiple international institutes led to the incorporation of new SOPs and trainings for laboratory procedures; biosafety, biosurety, and biosecurity methods; performance of rickettsia-specific assays; and the identification of known and unknown rickettsial agents through the introduction of new serologic and molecular assays that complemented traditional microbiology methods.


2013 ◽  
Vol 18 (32) ◽  
Author(s):  
J Jones ◽  
J Lawrence ◽  
L Payne Hallström ◽  
J Mantero ◽  
H Kirkbride ◽  
...  

Surveillance for possible international infectious disease threats to the Olympic and Paralympic Games in London, United Kingdom, was conducted from 2 July to 12 September 2012 by a collaborative team comprising representatives from the Health Protection Agency (Public Health England since April 2013), the European Centre for Disease Prevention and Control and the National Travel Health Network and Centre. Team members enhanced their usual international surveillance activities and undertook joint risk assessments of incidents identified as relevant through an agreed set of criteria designed for the Games and using tools developed for this purpose. Although team members responded to a range of international disease incidents as part of their routine roles during this period, no incident was identified that represented a threat to the Games. Six incidents were highlighted by the team that were likely to attract media attention and hence could generate political and public concern. Responding to such concern is an important aspect of the overall public health management of mass gathering events. The lessons learned about the process and outcomes of the enhanced international surveillance will help inform planning by future hosts of similar events.


2017 ◽  
Vol 9 (1) ◽  
Author(s):  
Alina Deshpande ◽  
Kristin Margevicius

Objective1. To develop a comprehensive model characterization frameworkto describe epidemiological models in an operational context.2. To apply the framework to characterize “operational” modelsfor specific infectious diseases and provide a web-based directory,the biosurveillance analytics resource directory (BARD) to the globalinfectious disease surveillance community.IntroductionEpidemiological modeling for infectious disease is useful fordisease management and routine implementation needs to befacilitated through better description of models in an operationalcontext. A standardized model characterization process that allowsselection or making manual comparisons of available models andtheir results is currently lacking. Los Alamos National Laboratory(LANL) has developed a comprehensive framework that can be usedto characterize an infectious disease model in an operational context.We offer this framework and an associated database to stakeholders ofthe infectious disease modeling field as a tool for standardizing modeldescription and facilitating the use of epidemiological models. Such aframework could help the understanding of diverse models by variousstakeholders with different preconceptions, backgrounds, expertise,and needs, and can foster greater use of epidemiological models astools in infectious disease surveillance.MethodsWe define, “operational” as the application of an epidemiologicalmodel to a real-world event for decision support and can be used byexperts and non-experts alike. The term “model” covers three majortypes, risk mapping, disease dynamics and anomaly detection.To develop a framework for characterizing epidemiological modelswe collected information via a three-step process: a literature searchof model characteristics, a review of current operational infectiousdisease epidemiological models, and subject matter expert (SME)panel consultation. We limited selection of operational models tofive infectious diseases: influenza, malaria, dengue, cholera andfoot-and-mouth disease (FMD). These diseases capture a varietyof transmission modes, represent high or potentially high epidemicor endemic burden, and are well represented in the literature. Wealso developed working criteria for what attributes can be used tocomprehensively describe an operational model including a model’sdocumentation, accessibility, and sustainability.To apply the model characterization framework, we built theBARD, which is publicly available (http://brd.bsvgateway.org).A document was also developed to describe the usability requirementsfor the BARD; potential users (and non-users) and use cases areformally described to explain the scope of use.Results1. Framework for model characterizationThe framework is divided into six major components (Figure 1):Model Purpose, Model Objective, Model Scope, Biosurveillance(BSV) goals, Conceptual Model and Model Utility; each of whichhas several sub-categories for characterizing each aspect of a model.2. Application to model characterizationModels for five infectious diseases—cholera, malaria, influenza,FMD and dengue were characterizedusing the framework and are included in the BARD database. Ourframework characterized disparate models in a streamlined fashion.Model information could be binned into the same categories, allowingeasy manual comparison and understanding of the models.3. Development of the BARDOur model characterization framework was implemented into anactionable tool which provides specific information about a modelthat has been systematically categorized. It allows manual categoryto-category comparison of multiple models for a single disease andwhile the tool does not rank models it provides model information ina format that allows a user to make a ranking or an assessment of theutility of the model.ConclusionsWith the model characterization framework we hope to encouragemodel developers to start describing the many features of their modelsusing a common format. We illustrate the application of the frameworkthrough the development of the BARD which is a scientific andnon-biased tool for selecting an appropriate epidemiological modelfor infectious disease surveillance. Epidemiological models are notnecessarily being developed with decision makers in mind. This gapbetween model developers and decision makers needs to be narrowedbefore modeling becomes routinely implemented in decision making.The characterization framework and the tool developed (BARD) area first step towards addressing this gap.Keywordsepidemiological models; database; decision support


2019 ◽  
Vol 10 (1) ◽  
pp. 94-115
Author(s):  
Stephen L ROBERTS

This article investigates the rise of algorithmic disease surveillance systems as novel technologies of risk analysis utilised to regulate pandemic outbreaks in an era of big data. Critically, the article demonstrates how intensified efforts towards harnessing big data and the application of algorithmic processing techniques to enhance the real-time surveillance and regulation infectious disease outbreaks significantly transform practices of global infectious disease surveillance; observed through the advent of novel risk rationalities which underpin the deployment of intensifying algorithmic practices to increasingly colonise and patrol emergent topographies of data in order to identify and govern the emergence of exceptional pathogenic risks. Conceptually, this article asserts further howthe rise of these novel risk regulating technologies within a context of big data transforms the government and forecasting of epidemics and pandemics: illustrated by the rise of emergent algorithmic governmentalties of risk within contemporary contexts of big data, disease surveillance and the regulation of pandemic.


2013 ◽  
Vol 6 (1) ◽  
pp. 19958 ◽  
Author(s):  
Mark M. Rweyemamu ◽  
Peter Mmbuji ◽  
Esron Karimuribo ◽  
Janusz Paweska ◽  
Dominic Kambarage ◽  
...  

2015 ◽  
Vol 121 (3-4) ◽  
pp. 306-313 ◽  
Author(s):  
Marcos Amaku ◽  
José Henrique de Hildebrand Grisi-Filho ◽  
Rísia Lopes Negreiros ◽  
Ricardo Augusto Dias ◽  
Fernando Ferreira ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document